Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Contemporary Clinical Trials Communications
|
May 24, 2021
The importance of loss functions: A note on the evolution of the Toxicity Probability Interval design
Jonathan Siegel
Journal of the Association for Research in Otolaryngology : JARO
|
September 30, 2021
Distortion Product Otoacoustic Emission (DPOAE) Growth in Aging Ears with Clinically Normal Behavioral Thresholds
Courtney Coburn Glavin, Jonathan Siegel, Sumitrajit Dhar
ENT & Audiology News
|
August 4, 2015
Clinical Utilisation of High-frequency DPOAEs
Gayla Poling, Jungmee Lee, Jonathan Siegel, et al.
Hearing Research
|
March 2, 2025
Frequency and level dependence of the middle ear acoustic reflex and its decay measured in wideband absorbance with contralateral narrowband noise elicitors
Abbie Baricevich, Danielle Bassett, Sophia Chan, et al.
Ear and Hearing
|
July 2, 2019
The Association Between Physiological Noise Levels and Speech Understanding in Noise
Samantha Stiepan, Jonathan Siegel, Jungwha Lee, et al.
Translational Stroke Research
|
April 18, 2022
Impact of Electronic Cigarette Vaping on Cerebral Ischemia: What We Know So Far
Jonathan Siegel, Shahil H Patel, Berk Mankaliye, et al.
Melanoma Research
|
November 5, 2011
Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial
Jeffrey S Weber, Asim Amin, David Minor, et al.
Ear and Hearing
|
March 23, 2012
Behavioral hearing thresholds between 0.125 and 20 kHz using depth-compensated ear simulator calibration
Jungmee Lee, Sumitrajit Dhar, Rebekah Abel, et al.
Frontiers in Sports and Active Living
|
December 21, 2020
Walking With Ears: Altered Auditory Feedback Impacts Gait Step Length in Older Adults
Tara Cornwell, Jane Woodward, Mengnan/Mary Wu, et al.
Cancer Immunity
|
November 25, 2010
Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma
David Berman, Susan M Parker, Jonathan Siegel, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Contemporary Clinical Trials Communications
|
May 24, 2021
The importance of loss functions: A note on the evolution of the Toxicity Probability Interval design
Jonathan Siegel
Journal of the Association for Research in Otolaryngology : JARO
|
September 30, 2021
Distortion Product Otoacoustic Emission (DPOAE) Growth in Aging Ears with Clinically Normal Behavioral Thresholds
Courtney Coburn Glavin, Jonathan Siegel, Sumitrajit Dhar
ENT & Audiology News
|
August 4, 2015
Clinical Utilisation of High-frequency DPOAEs
Gayla Poling, Jungmee Lee, Jonathan Siegel, et al.
Hearing Research
|
March 2, 2025
Frequency and level dependence of the middle ear acoustic reflex and its decay measured in wideband absorbance with contralateral narrowband noise elicitors
Abbie Baricevich, Danielle Bassett, Sophia Chan, et al.
Ear and Hearing
|
July 2, 2019
The Association Between Physiological Noise Levels and Speech Understanding in Noise
Samantha Stiepan, Jonathan Siegel, Jungwha Lee, et al.
Translational Stroke Research
|
April 18, 2022
Impact of Electronic Cigarette Vaping on Cerebral Ischemia: What We Know So Far
Jonathan Siegel, Shahil H Patel, Berk Mankaliye, et al.
Melanoma Research
|
November 5, 2011
Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial
Jeffrey S Weber, Asim Amin, David Minor, et al.
Ear and Hearing
|
March 23, 2012
Behavioral hearing thresholds between 0.125 and 20 kHz using depth-compensated ear simulator calibration
Jungmee Lee, Sumitrajit Dhar, Rebekah Abel, et al.
Frontiers in Sports and Active Living
|
December 21, 2020
Walking With Ears: Altered Auditory Feedback Impacts Gait Step Length in Older Adults
Tara Cornwell, Jane Woodward, Mengnan/Mary Wu, et al.
Cancer Immunity
|
November 25, 2010
Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma
David Berman, Susan M Parker, Jonathan Siegel, et al.
Page
of 2